BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 38502982)

  • 1. Acquired Cystic Disease-Associated Renal Cell Carcinoma: A Systematic Review and Meta-analysis.
    Duong NX; Le MK; Nguyen TT; Nguyen DD; Vuong HG; Kondo T; Mitsui T
    Clin Genitourin Cancer; 2024 Jun; 22(3):102050. PubMed ID: 38502982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparable survival outcome between acquired cystic disease associated renal cell carcinoma and clear cell carcinoma in patients with end-stage renal disease: a multi-institutional central pathology study.
    Kondo T; Sassa N; Yamada H; Takagi T; Iizuka J; Kobayashi H; Yoshida K; Fukuda H; Ishihara H; Tanabe K; Tsuzuki T
    Pathology; 2021 Oct; 53(6):720-727. PubMed ID: 33947521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acquired cystic disease-associated renal cell carcinoma is the most common subtype in long-term dialyzed patients: Central pathology results according to the 2016 WHO classification in a multi-institutional study.
    Kondo T; Sasa N; Yamada H; Takagi T; Iizuka J; Kobayashi H; Yoshida K; Fukuda H; Ishihara H; Tanabe K; Tsuzuki T
    Pathol Int; 2018 Oct; 68(10):543-549. PubMed ID: 30187581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acquired Cystic Disease-associated Renal Cell Carcinoma (ACD-RCC): A Multiinstitutional Study of 40 Cases With Clinical Follow-up.
    Przybycin CG; Harper HL; Reynolds JP; Magi-Galluzzi C; Nguyen JK; Wu A; Sangoi AR; Liu PS; Umar S; Mehra R; Zhang X; Cox RM; McKenney JK
    Am J Surg Pathol; 2018 Sep; 42(9):1156-1165. PubMed ID: 29851703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acquired Cystic Kidney Disease-associated Renal Cell Carcinoma (ACKD-RCC) Harbor Recurrent Mutations in KMT2C and TSC2 Genes.
    Shah A; Lal P; Toorens E; Palmer MB; Schwartz L; Vergara N; Guzzo T; Nayak A
    Am J Surg Pathol; 2020 Nov; 44(11):1479-1486. PubMed ID: 32604168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acquired cystic disease subtype renal cell carcinoma (ACD-RCC): prevalence and imaging features at a single institution.
    Carnahan MB; Kunzelman J; Kawashima A; Patel BN; Menias CO; Fananapazir G
    Abdom Radiol (NY); 2022 Aug; 47(8):2858-2866. PubMed ID: 35674787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomic profiling of renal cell carcinoma in patients with end-stage renal disease.
    Inoue T; Matsuura K; Yoshimoto T; Nguyen LT; Tsukamoto Y; Nakada C; Hijiya N; Narimatsu T; Nomura T; Sato F; Nagashima Y; Kashima K; Hatakeyama S; Ohyama C; Numakura K; Habuchi T; Nakagawa M; Seto M; Mimata H; Moriyama M
    Cancer Sci; 2012 Mar; 103(3):569-76. PubMed ID: 22145865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive Clinicopathologic Analyses of Acquired Cystic Disease-associated Renal Cell Carcinoma With Focus on Adverse Prognostic Factors and Metastatic Lesions.
    Kojima F; Gandhi JS; Matsuzaki I; Iba A; Collier S; Yoshikawa T; Kinoshita Y; Warigaya K; Fujimoto M; Kuroda N; Morii E; Hara I; Murata SI; Amin MB
    Am J Surg Pathol; 2020 Aug; 44(8):1031-1039. PubMed ID: 32271189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paneth-like cells in renal cell carcinomas and in cysts associated with acquired cystic kidney disease: Clinicopathologic analysis, comparative study and description of precursor lesions.
    Kojima F; Alaghehbandan R; Kuroda N; Matsuzaki I; Mikasa Y; Musangile FY; Iwamoto R; Takahashi Y; Iwahashi Y; Warigaya K; Iba A; Hara I; Murata SI; Hes O
    Ann Diagn Pathol; 2021 Apr; 51():151707. PubMed ID: 33516060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acquired cystic disease-associated renal cell carcinoma: A clinicopathologic study of eight tumors with clinical follow-up.
    ChrabaƄska M; Ryszawy J; Drozdzowska B
    Indian J Cancer; 2021; 58(4):608-614. PubMed ID: 34975102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acquired cystic disease-associated renal cell carcinoma with gain of chromosomes 3, 7, and 16, gain of chromosome X, and loss of chromosome Y.
    Kuroda N; Shiotsu T; Hes O; Michal M; Shuin T; Lee GH
    Med Mol Morphol; 2010 Dec; 43(4):231-4. PubMed ID: 21267700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spectrum of epithelial neoplasms in end-stage renal disease: an experience from 66 tumor-bearing kidneys with emphasis on histologic patterns distinct from those in sporadic adult renal neoplasia.
    Tickoo SK; dePeralta-Venturina MN; Harik LR; Worcester HD; Salama ME; Young AN; Moch H; Amin MB
    Am J Surg Pathol; 2006 Feb; 30(2):141-53. PubMed ID: 16434887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic and epigenetic profiling indicates the proximal tubule origin of renal cancers in end-stage renal disease.
    Ishihara H; Yamashita S; Liu YY; Hattori N; El-Omar O; Ikeda T; Fukuda H; Yoshida K; Takagi T; Taneda S; Kondo T; Nagashima Y; Tanabe K; Ushijima T
    Cancer Sci; 2020 Nov; 111(11):4276-4287. PubMed ID: 32860304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal cell carcinoma in patients with end-stage renal disease: relationship between histological type and duration of dialysis.
    Nouh MA; Kuroda N; Yamashita M; Hayashida Y; Yano T; Minakuchi J; Taniguchi S; Nomura I; Inui M; Sugimoto M; Kakehi Y
    BJU Int; 2010 Mar; 105(5):620-7. PubMed ID: 19747356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathologic characterization of renal epithelial neoplasms arising in nonfunctioning kidneys.
    Lin X; Goyal R; Yang XJ
    Hum Pathol; 2020 Mar; 97():1-7. PubMed ID: 31857138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical and molecular genetic profiling of acquired cystic disease-associated renal cell carcinoma.
    Pan CC; Chen YJ; Chang LC; Chang YH; Ho DM
    Histopathology; 2009 Aug; 55(2):145-53. PubMed ID: 19694821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Renal cell carcinoma in patients with end-stage renal disease: a clinicopathological analysis].
    He B; Zhang W; Liu LN; Wang H; Zou YW; Jiang YX; Yu WJ; Shi HL; Liu Y; Li YJ
    Zhonghua Bing Li Xue Za Zhi; 2019 Nov; 48(11):846-850. PubMed ID: 31775432
    [No Abstract]   [Full Text] [Related]  

  • 18. Histologic subtype needs to be considered after partial nephrectomy in patients with pathologic T1a renal cell carcinoma: papillary vs. clear cell renal cell carcinoma.
    Yoo S; You D; Jeong IG; Song C; Hong B; Hong JH; Ahn H; Kim CS
    J Cancer Res Clin Oncol; 2017 Sep; 143(9):1845-1851. PubMed ID: 28451753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acquired cystic disease-associated renal cell carcinoma with sarcomatoid change and rhabdoid features.
    Kuroda N; Tamura M; Hamaguchi N; Mikami S; Pan CC; Brunelli M; Martignoni G; Hes O; Michal M; Lee GH
    Ann Diagn Pathol; 2011 Dec; 15(6):462-6. PubMed ID: 21036640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clear cell-papillary renal cell carcinoma of the kidney not associated with end-stage renal disease: clinicopathologic correlation with expanded immunophenotypic and molecular characterization of a large cohort with emphasis on relationship with renal angiomyoadenomatous tumor.
    Aron M; Chang E; Herrera L; Hes O; Hirsch MS; Comperat E; Camparo P; Rao P; Picken M; Michal M; Montironi R; Tamboli P; Monzon F; Amin MB
    Am J Surg Pathol; 2015 Jul; 39(7):873-88. PubMed ID: 25970682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.